Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2026-01-16 @ 8:46 PM
Study NCT ID:
NCT03622112
Status:
COMPLETED
Last Update Posted:
2020-11-27
First Post:
2018-07-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Asthma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Inhaled non-steroidal glucocorticoid receptor modulator | View |
| None | Asthma | View |
| None | Inhaled corticosteroids. | View |
| None | Glucocorticoid receptor (GA) agonists. | View |
| None | Chronic obstructive pulmonary disease. | View |
| None | Short-acting B2 agonist. | View |
| None | Fluticasone furoate. | View |